Clinical Trial Update: Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric +3 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial results on visual function after implantation of bilateral AcrySof ReSTOR Aspheric +3 intraocular lenses in cataract patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• AcrySof ReSTOR Aspheric +3 intraocular lens (intraocular lens)

Snippet

Sponsor: Alcon Research | Conditions: Cataract | Phase 4 | Status: COMPLETED | Results posted: 2010-03-16